CoChat

SARS-COV-2 Variants: Differences and Potential of Immune Evasion

Open access
Hirabara, Sandro M., Serdan, Tamires D. A., Gorjao, Renata, Masi, Laureane N., Pithon-Curi, Tania C., Covas, Dimas T., Curi, Rui, Durigon, Edison L. · 2022 · Frontiers in Cellular and Infection Microbiology
Cited by 226

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

The structural spike (S) glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) plays an essential role in infection and is an important target for neutralizing antibody recognition. Mutations in the S gene can generate variants of concern (VOCs), which improve “viral fitness” through selective or survival advantages, such as increased ACE-2 receptor affinity, infectivity, viral replication, higher transmissibility, resistance to neutralizing antibodies and immune escape, increasing disease severity and reinfection risk. Five VOCs have been recognized and include B.1.1.7 (U.K.), B.1.351 (South Africa), P.1 (Brazil), B.1.617.2 (India), and B.1.1.529 (multiple countries). In this review, we addressed the following critical points concerning VOCs: a) characteristics of the SARS-CoV-2 VOCs with mutations in the S gene; b) possible evasion of variants from neutralizing antibodies generated through vaccination, previous infection, or immune therapies; c) potential risk of new pandemic waves induced by the variants worldwide; and d) perspectives for further studies and actions aimed at preventing or reducing the impact of new variants during the current COVID-19 pandemic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcimb.2021.781429

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 226

Metadata

Authors
Hirabara, S. M., Serdan, T. D. A., Gorjao, R., Masi, L. N., Pithon-Curi, T. C., Covas, D. T., Curi, R., & Durigon, E. L.
Venue
Frontiers in Cellular and Infection Microbiology
Published
2022-01-18
Volume
11
Pages
781429-781429
ISSN
2235-2988 (ISSN-L)
OpenAlex
W4206774592
Cited by
226
References
47
FWCI
24.95
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS-COV-2 Variants: Differences and Potential of Immune Evasion. https://app.cochat.ai/papers/10.3389/fcimb.2021.781429
The paper
Hirabara, S. M., Serdan, T. D. A., Gorjao, R., Masi, L. N., Pithon-Curi, T. C., Covas, D. T., Curi, R., & Durigon, E. L. (2022). SARS-COV-2 Variants: Differences and Potential of Immune Evasion. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2021.781429

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.